Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Chang

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 23, 2016
Evaluation of nasal patency by visual analogue scale/nasal obstruction symptom evaluation questionnaires and anterior active rhinomanometry after septoplasty: a retrospective one-year follow-up cohort studyH C Hsu, C D Tan, C W Chang, et al.
Journal of Medicinal Chemistry|May 12, 2006
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonistsLisa C W Chang, Ronald F Spanjersberg, Jacobien K von Frijtag Drabbe Künzel, et al.
Gut|April 15, 2008
Vomiting and a target sign on abdominal CTC-W Chang, W-S Liao, S-C Shih, et al.
The Journal of International Medical Research|January 17, 2013
Relationship between changes in components associated with metabolic syndrome and disappearance, or remission, of metabolic syndrome during 1 yearH-C Chang, J-T Horng, T-T Chau, et al.
Transfusion Medicine (Oxford, England)|September 17, 2016
Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi<sup>a</sup> ' records decreases transfusion reaction rates in TaiwanC-A Yang, J-A Lin, C-W Chang, et al.
Journal of Medicinal Chemistry|February 16, 2007
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonistsLisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, Thea Mulder-Krieger, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 25, 2009
The robotic radiosynthesis of 5-[(18)F]fluoro-2'-deoxyuridine and its biological characterizationC W Chang, Y Y Lin, C J Peng, et al.
Nanotechnology|October 12, 2010
Green fabrication of agar-conjugated Fe3O4 magnetic nanoparticlesS Hsieh, B Y Huang, S L Hsieh, et al.
Acta Oncologica (Stockholm, Sweden)|June 19, 2023
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric featuresD Bohannon, J Janopaul-Naylor, S Rudra, et al.
Journal of Medicinal Chemistry|July 9, 2004
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosineMargot W Beukers, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 23, 2016
Evaluation of nasal patency by visual analogue scale/nasal obstruction symptom evaluation questionnaires and anterior active rhinomanometry after septoplasty: a retrospective one-year follow-up cohort studyH C Hsu, C D Tan, C W Chang, et al.
Journal of Medicinal Chemistry|May 12, 2006
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonistsLisa C W Chang, Ronald F Spanjersberg, Jacobien K von Frijtag Drabbe Künzel, et al.
Gut|April 15, 2008
Vomiting and a target sign on abdominal CTC-W Chang, W-S Liao, S-C Shih, et al.
The Journal of International Medical Research|January 17, 2013
Relationship between changes in components associated with metabolic syndrome and disappearance, or remission, of metabolic syndrome during 1 yearH-C Chang, J-T Horng, T-T Chau, et al.
Transfusion Medicine (Oxford, England)|September 17, 2016
Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi<sup>a</sup> ' records decreases transfusion reaction rates in TaiwanC-A Yang, J-A Lin, C-W Chang, et al.
Journal of Medicinal Chemistry|February 16, 2007
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonistsLisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, Thea Mulder-Krieger, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 25, 2009
The robotic radiosynthesis of 5-[(18)F]fluoro-2'-deoxyuridine and its biological characterizationC W Chang, Y Y Lin, C J Peng, et al.
Nanotechnology|October 12, 2010
Green fabrication of agar-conjugated Fe3O4 magnetic nanoparticlesS Hsieh, B Y Huang, S L Hsieh, et al.
Acta Oncologica (Stockholm, Sweden)|June 19, 2023
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric featuresD Bohannon, J Janopaul-Naylor, S Rudra, et al.
Journal of Medicinal Chemistry|July 9, 2004
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosineMargot W Beukers, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, et al.
Pageof 20